Aurobindo Pharma's US-based joint venture Cephazone Pharma LLC has received approval for its original ANDAs for ceftiofur sodium sterile powder from the US FDA for veterinary medicines.

Ceftofur is the generic equivalent of Pfizer's Naxcel for injection. The product is approved for treatment of various bacterial infections in dogs, horses, cattle, swine, sheep, day-old chickens and day-old turkey poults.

Cephazone Pharma is a 50:50 joint venture formed in 2001 between Aurobindo's wholly owned subsidiary APL Holdings Inc in association with Geravi Inc, a subsidiary of Medpharmex, USA to manufacture sterile and non-sterile cephalosporin products.